You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 24, 2025

Drug Price Trends for CHILD CETIRIZINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CHILD CETIRIZINE

Average Pharmacy Cost for CHILD CETIRIZINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CHILD CETIRIZINE HCL 1 MG/ML 70752-0104-06 0.03586 ML 2025-05-21
CHILD CETIRIZINE HCL 1 MG/ML 00904-6765-20 0.03586 ML 2025-05-21
CHILD CETIRIZINE 10 MG CHEW TB 47335-0344-83 2.30393 EACH 2025-05-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Cetirizine Hydrochloride

Overview of Cetirizine Hydrochloride

Cetirizine hydrochloride, commonly known by brand names such as Zyrtec and Aller-Tec, is a second-generation antihistamine widely used to treat various allergic conditions, including allergic rhinitis, allergic conjunctivitis, eczema, and urticaria. Here’s a comprehensive analysis of the market and price projections for this drug.

Market Size and Growth

As of 2024, the global cetirizine hydrochloride market was valued at approximately $6.3 billion and is projected to grow at a Compound Annual Growth Rate (CAGR) of 2.6% to reach $8.0 billion by 2034[1][3].

Key Drivers

Increasing Prevalence of Allergic Diseases

The rising rates of allergic diseases such as eczema, food allergies, and allergic rhinitis are significant drivers of the cetirizine hydrochloride market. For instance, a report by the CDC’s National Center for Health Statistics indicated that more than 1 in 4 American children and over 1 in 3 American adults reported having a food allergy, eczema, or seasonal allergy in 2021[1].

Demographic Expansion

The drug's efficacy and safety profile have made it a preferred choice across various demographics, from pediatric to geriatric populations. The availability of generic formulations has further increased its accessibility, driving down prices and making it more affordable for a broader range of consumers[1][3].

Regional Insights

North America

The North American market is expected to witness a significant revenue share due to the high incidence of allergic rhinitis and urticaria in this region. The growing financial burden of allergic disorders on the population also contributes to the market's expansion[1].

Asia Pacific

This region is anticipated to experience the fastest revenue growth, driven by an aging population, increased disposable income, and rising allergy awareness. Developing nations in the Asia Pacific offer considerable market potential for cetirizine hydrochloride[1].

Europe

The European market is expanding steadily, influenced by an aging population and the increasing prevalence of allergies among senior citizens[1].

Latin America and Middle East & Africa

Latin America is an emerging market with increasing healthcare spending due to a growing middle class, while the Middle East and Africa are in the developmental stages, with growth propelled by improving healthcare infrastructure and rising allergy awareness[1][3].

Market Segmentation

By Dosage Form

Cetirizine hydrochloride is available in various forms, including tablets, syrup, and solution. Each form caters to different patient needs and preferences, contributing to the market's diversity and growth[3].

By Age Group

The drug is used across different age groups, including adults and pediatric populations. The pediatric segment is particularly significant, given the drug's safety and efficacy in children older than 6 months[4][5].

By Application

Cetirizine hydrochloride is used to treat a range of allergic conditions, including allergic rhinitis, allergic conjunctivitis, eczema, and others. This versatility enhances its market potential[3].

By Distribution Channel

The drug is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, ensuring wide accessibility and contributing to market growth[3].

Price Projections and Budget Impact

Cost Considerations

The cost of cetirizine hydrochloride can vary based on contractual agreements and distribution channels. For instance, the adoption of intravenous cetirizine in emergency departments has shown a positive budget impact, with estimated annual net revenue increases due to earlier patient discharge and freed bed space[2].

Generic Formulations

The introduction of generic versions of cetirizine hydrochloride has increased competition, leading to lower prices and greater accessibility. This trend is expected to continue, making the drug more affordable for a broader range of consumers[1][3].

Challenges and Restraints

Regulatory Frameworks

Stringent laws and regulations can restrict the growth of the cetirizine hydrochloride market. Compliance with these regulations is crucial for market players to ensure continued market presence[1].

Development of New Medications

The potential development of new medications could slow the growth rate of the cetirizine hydrochloride market. However, the established safety and efficacy profile of cetirizine hydrochloride are likely to maintain its market position[1].

Key Takeaways

  • The global cetirizine hydrochloride market is valued at $6.3 billion in 2024 and is projected to grow to $8.0 billion by 2034.
  • Rising allergic disease prevalence and the drug's safety and efficacy across various demographics drive market growth.
  • Regional markets, especially in North America and the Asia Pacific, are expected to contribute significantly to the market's expansion.
  • Generic formulations and diverse distribution channels enhance market accessibility and affordability.
  • Regulatory frameworks and the development of new medications are key challenges to market growth.

FAQs

What is the current market size of cetirizine hydrochloride?

The global cetirizine hydrochloride market was valued at approximately $6.3 billion in 2024[1].

What is the projected growth rate of the cetirizine hydrochloride market?

The market is projected to grow at a CAGR of 2.6% from 2024 to 2034[1].

Which regions are expected to drive the growth of the cetirizine hydrochloride market?

North America and the Asia Pacific are expected to be significant drivers of market growth due to high allergy prevalence and demographic factors[1].

What are the main drivers of the cetirizine hydrochloride market?

The main drivers include the increasing prevalence of allergic diseases, the drug's safety and efficacy profile, and the availability of generic formulations[1][3].

How does the introduction of generic formulations impact the market?

The introduction of generic formulations increases competition, drives down prices, and makes cetirizine hydrochloride more accessible to a broader range of consumers[1][3].

What are the potential challenges to the growth of the cetirizine hydrochloride market?

Key challenges include stringent regulatory frameworks and the potential development of new medications[1].

Sources

  1. Prophecy Market Insights: Global Cetirizine Hydrochloride Market By Overview[1].
  2. AHDB Online: Budget Impact of Intravenous Cetirizine Hydrochloride for the Treatment of Acute Urticaria in the Emergency Department Setting[2].
  3. Reanin: Global Cetirizine Hydrochloride Market | Growth | Size | Trends and Forecast[3].
  4. FDA: Zyrtec (cetirizine hydrochloride) tablets and syrup for oral use[4].
  5. NCBI Bookshelf: Cetirizine - StatPearls[5].
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.